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Percutaneous balloon dilation of the aortic valve has
recently been proposed as a palliative procedure for
treating nonsurgical candidates with calcific aortic ste-
nosis. To assess the safety, efficacy and mechanisms of
successful balloon valvuloplasty, postmortem (n = 33)
and intraoperative (n = 6) balloon aortic valvuloplasty
was performed in the hearts of 39 elderly patients with
calcific aortic stenosis. The cause of aortic stenosis was
degenerative nodular calcification in 28 cases, calcific
bicuspid aortic stenosis in 8 cases and rheumatic heart
disease in 3 cases. Balloon dilation was performed with
15 to 25 mm balloons in the postmortem specimens, and
with 18 to 20 mm balloons in the operating room im-
mediately before aortic valve replacement.
After balloon dilation, valve orifice dimensions and
As an alternative to aortic valve replacement, percutaneous
balloon dilation of the aortic valve has been proposed by
Cribier et al. (I) and our laboratory (2) for treating high
risk elderly patients with calcific aortic stenosis. Balloon
valvuloplasty has been accomplished successfully in chil-
dren with a variety of congenital cardiovascular disorders
(3-7), but this procedure has only recently been attempted
in adults, primarily because of fears of potential compli-
cations, including embolization of calcific debris, valve ring
disruption, acute valvular regurgitation and valvular reste-
nosis.
On the basis of preliminary postmortem and intraoper-
ative studies, we (2) reported several mechanisms of suc-
cessful dilation, including fracture of nodular calcification,
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leafletmobility increased in all patients. The mechanisms
of successful dilation included fracture of calcified nod-
ules in 16 aortic valves, separation of fused commissures
in 5 valves, both in 6 valves and grossly inapparent
microfractures in 12 valves. Valve leaflet avulsion oc-
curred in one heart after inflation with a clearly over-
sized balloon. Liberation of calcific debris, valve ring
disruption or midleaflet tears did not occur in any heart.
In conclusion, there are at least three mechanisms of
successful aortic valvuloplasty, depending on the origin
of valvular stenosis. Embolic phenomena and acute val-
vular regurgitation do not appear to be likely events
associated with this procedure.
(J Am Coli Cardiol 1987;9:655-60)
separation of fused commissures and sttetching of rigid valve
leaflets. The purpose of this study was to assess the safety,
efficacy and mechanisms of successful balloon dilation in
the hearts of 39 elderly patients with calcific aortic stenosis.
The importance of appropriate balloon size and its impact
on myocardial perfusion and left ventricular function is em-
phasized.
Methods
Postmortem valvuloplasty. All patients undergoing
postmortem examination who had evidence for aortic ste-
nosis were considered for study. Valves were examined by
a pathologist to determine the number of cusps, the presence
of commissural fusion and the degree of leaflet distortion.
Aortic valvuloplasty was subsequently performed in 33
hearts-6 fresh specimens and 27 formalin-fixed speci-
mens-using angioplasty catheters with 15 to 25 mm bal-
loons (Meditech). After dilation, detailed gross examina-
tions were performed to assess changes in orifice dimensions
and leaflet mobility and evidence for separation of com-
missures and fracture of calcific nodules. All valves were
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carefully examined for evidence of valve ring disruption and
leaflet tears to assess the potential for acute valvular regur-
gitation. All valves were inspected visually and by palpa-
tion, before and after dilation, to determine the presence of
calcific valve debris. In addition, photographs of all spec-
imens were made before and after dilation, and these were
scrutinized for evidence of dislodgment of valve debris that
could serve as a source for distal embolization.
Intraoperative valvuloplasty. All patients undergoing
aortic valve replacement for critical aortic stenosis were
considered for study. All six patients entered gave informed
consent for intraoperative valvuloplasty, according to a pro-
tocol approved by the Beth Israel Hospital Human Studies
Committee. After institution of cardiopulmonary bypass,
cross clamping of the aorta and cannulation of the coronary
arteries, a detailed inspection of the valve was performed
as described previously. Each of the six balloon dilations
was performed retrograde through the aortic valve using an
18 to 20 mm balloon, before aortic valve replacement. After
dilation, detailed gross examinations were performed as in
the postmortem specimens.
Results
Clinical features. Postmortem or intraoperative balloon
aortic valvuloplasty was performed in 39 patients with se-
vere aortic stenosis and a mean age of 70 years. The cause
of aortic stenosis was degenerative nodular calcification in
28 cases (72%), calcific bicuspid aortic stenosis in 8 (21 %)
and rheumatic heart disease in 3 (8%).
Anatomic findings. Gross examination of the valves
before balloon dilation revealed cusp rigidity and limited
leaflet mobility in all patients. Extensive commissural fusion
was present in II patients, including 8 with congenital com-
missural fusion and 3 with a history of rheumatic heart
disease. Less extensive fusion at the periphery of the com-
missures was present in 9 of 28 patients with degenerative
nodular calcification and in 5 of 8 patients with congenital
bicuspid aortic stenosis.
After balloon valvuloplasty, leaflet mobility and valve
orifice dimensions increased in all specimens. However, the
mechanism of successful dilation varied. The most common
mechanism for success, fracture of calcified nodules, was
the sole occurrence in 16 valves (Fig. I and 2). Five valves
had evidence for separation of fused commissures alone,
and six had evidence for both fracture of calcific nodules
and separation of fused commissures.
In the eight aortic valves with congenital commissural
fusion, there were no instances of separation along the con-
genitally fused commissure (Fig. 2). However, commissural
separation was the primary mechanism for success in the
valves of three patients with a history of rheumatic heart
disease (Fig. 3). Commissural separation contributed to suc-
cessful dilation in 8 of 14 patients with peripheral com-
missural fusion (Fig. 4).
A
B
Figure 1. A, Postmortem aortic valve before valvuloplasty dem-
onstrating extensive nodular calcification, especially of the non-
coronary cusp. B, After valvuloplasty, valve orifice dimensions
and leaflet mobility have increased, and a large fracture is evident
in the calcified nodule on the noncoronary cusp.
Increases in leaflet mobility and orifice dimensions were
due to simple stretching of leaflets without associated frac-
tures of calcified nodules or separation of commissures in
12 aortic valves (Fig. 5). The most likely explanation for
successful dilation in these valves was the presence of grossly
inapparent leaflet microfractures.
Thus, of39 balloon dilations, success could be attributed
to fracture of degenerative nodular calcifications in 16 aortic
valves, separation of fused commissures in 5 valves, both
fracture of calcified nodules and separation of commissures
in 6 valves and grossly inapparent microfractures in 12
valves.
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A
B
Figure 2. A. Postmortem congenital bicusp id aortic valve before
valvuloplasty demon strat ing congenital fusion of the right and left
coronary cusps. and extensive nodular calc ificat ion of the non-
coronary cusp, B, After valvul opla sty , valve orifice dimen sions
and leaflet mobility have increased. and there is a fracture in the
calcified nodul e in the noncoronary cusp. The raphe between the
right and left cusps is not affected by ballo on dilation .
Potential adverse effects. One postmortem specimen
was succe ssfull y dilated with a 20 mm balloon. and further
dilation with a 25 mm balloon. which was clearly oversized
for this particular valve. resulted in avulsion of the valve
leaflet from the wall of the aorta. Liberation of calcific
debris, valve ring disrupti on or midleaflet tears did not occur
in any patients.
A
B
Figure 3. A, Postm ortem aortic valve before valvuloplasty dem-
onstrating extensive co mmissural fusion. espec ially between the
right and noncoronary cusps, due to rheum atic heart dise ase . B,
After valvuloplasty, orifice dimensions and leaflet mobility have
increas ed because of commissural separation .
Discussion
Pathology of aortic stenosis. The clinical application
of percutaneous balloon valvuloplasty to elderl y patients
with calc ific aortic and mitral stenosi s was recently reported
by several authors (1,2, 8-10). Our preliminary observations
on the morphologic basis for successful balloon aortic val-
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A
Figure 5. A, Postmortem bicuspid aortic valve before valvulo-
plasty demonstrating congenital fusion of the right and left coro-
nary cusps and extensive nodular calcification. 8, After valvulo-
plasty. orifice dimensions and leaflet mobility have increased,
although there is no gross evidence of commissural separation or
fracture of calcifi ed nodules. Successful dilation is presumably due
to grossly inapparent valve microfractures.
B
A
Figure 4. A, Postmortem aortic valve before valvuloplasty dem-
onstrating peripheral commissural fusion and moderate nodular
calcification. 8, After valvuloplasty, orifice dimensions and leaflet
mobility have increased as a result of separation of commissures
between the right and noncoronary cusps.
B
vuloplasty (2) have been extended and expanded by the
current study of 39 hearts with ca lcific aort ic stenosis. The
pathologic features of aortic stenosis in the elderl y are well
described ( I I). More than 90% of cases are due to degen-
erative calcification of one or more leaflets, calcification of
a congenital bicuspid valve , or postinflammatory (that is,
rheum atic) fibrosis with variou s degree s of calcification .
Whereas extensive nodular ca lcification is the hallmark of
degenerative aortic steno sis and accounts for most cases of
aortic stenosis in patient s over the age of 70 years . extensive
commissural fusion is the hallmark of postinflammatory types
of aortic stenosis (12). However , lesser degrees of com-
missural fusion, especiall y at the periphery of the commi s-
sure, may contribute to the outflow obstruction in valves
with extensive nodular calcification .
lACC Vol. 'I. No .1
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Mechanisms of successful valvuloplasty. In our study,
aortic stenosis was due to extensive degenerative nodular
calcification in 72%, calcification of a congenital bicuspid
valve in 21 % and rheumatic heart disease in 7%. Regardless
of the cause of aortic stenosis, balloon dilation was uni-
formly successful in increasing valveorificedimensions and
leaflet mobility. The morphologic basis for successful val-
vuloplasty includes fracture of calcified nodules, separation
of fused commissures and presumed grossly inapparent mi-
crofractures within the valve leaflets.
The single most common anatomic correlate ofsuccessful
dilation wasfracture ofcalcified nodules. whichcontributed
to relief of stenosis in 22 of the 39 hearts studied. Large
calcified nodules enhance the rigidity of the valve leaflets,
limit leaflet excursion and distort the normal lines of leaflet
closure, thus allowing for valvular regurgitation. After bal-
loon inflation, many large nodules were fractured, creating
an additional hinge point within the rigid leaflets and per-
mitting greater leaflet mobility. The enhancement of leaflet
mobility resulted in less distortion of the lines of leaflet
closure, which could cause a decrease in the degree of
stenosis without increasing the severity of aortic regurgi-
tation.
Another common mechanism for successful dilation was
separation offused commissures, whichcontributed to relief
of stenosis in II hearts. Fusion of commissures results in
limitation of leaflet excursion and, because the leaflets are
often fixed in position, valvular regurgitation is common.
Separation of commissures improves leaflet excursion, thereby
relieving stenosis, and it often tends to normalize leaflet
closure, which can prevent worsening aortic regurgitation.
The pattern of commissural fusion was an important de-
terminant of the likelihood of commissural separation after
valvuloplasty. In the eight hearts with congenital bicuspid
aortic stenosis, separation of the congenitally fused com-
missure did not occur. However, both extensive commis-
sural fusion associated with rheumatic heart disease and
peripheral commissural fusion can be easily separated with
balloon inflations.
It is of interestthat 27 (69%)of the 39 heartshadevidence
for fracture of calcified nodules or separation of commis-
sures, or both, whereas 12 hearts (31 %) exhibited increases
in leaflet mobility and orifice dimensions without obvious
gross morphologic changes in the valve. We postulated that
the mechanism for successful dilation in this latter group
was probably similar to that in the other patients but on a
microscopic level. Presumably, balloon dilation results in
microfractures within the leaflets, that are not evident by
gross inspection.
Clinical implications. The application of balloon val-
vuloplasty toelderlypatientswithaortic stenosiswas limited
initially by fears of embolization and abrupt development
of severe valvular regurgitation. In our study, there were
no instances of liberation of valve debris that could poten-
tially cause systemic emboli. In addition, midleaflet tears
and major changes in the configuration of valve leaflets did
not occur suggesting that severe acute aortic regurgitation
may not be common after balloon valvuloplasty. No leaflet
avulsions wereobserved when properly sized balloons were
used, although one leaflet avulsion occurred after postmor-
tem dilation with an oversized balloon.
Several observations made during postmortem and in-
traoperative valvuloplasty are potentially relevant to per-
cutaneous balloon aortic valvuloplasty:
I) Fractures within large calcified nodules are frequently
exposed to blood elements and may serve as a nidus for
deposition of plateletor fibrin, or both, and thus be potential
sources for systemicemboli. The role of anticoagulants and
aspirin has not been established in this setting, but their
benefit in coronary angioplasty and valvular heart disease
suggests that these drugs may be useful in patients after
valvuloplasty.
2) Balloon inflations mayhavea varietyof adverseeffects
on coronary perfusion and systemic arterial pressure. Large
calcified nodules may partially or completely occlude the
coronary ostia during balloon inflation, which could result
in myocardial ischemia or left ventricular dysfunction, or
both. Whereas inflation of relatively small balloons within
the orifice of a tricuspid aortic valve may permit sufficient
blood flow through nonfused commissures to maintain ar-
terial pressure, larger balloons may completelyocclude the
left ventricular outflow tract, resulting in profound hypo-
tension. These observations suggest that prolonged infla-
tions with small balloons may be possible without severe
hypotension, provided the commissures are not fused and
that large nodules do not occlude the coronary ostia. How-
ever, the development of angina or sustained hypotension
during balloon inflation may be an indication that the max-
imal safe balloon size has been attained.
3) In contrast to findings in the tricuspid aortic valve,
balloon inflations within a congenital bicuspid valve fre-
quently resulted in complete occlusion of the valve orifice,
even when smaller balloons were used. Hypotension may
therefore be common during valvuloplasty of bicuspid valves,
and may not be a reliable sign that the maximal safe balloon
size has been attained.
4) Finally, the successful dilation of several valves with
25 mm balloons cannot be taken as an endorsement of the
safety of these relatively large balloon sizes in all patients
with aortic stenosis. The ability to properlymatch a balloon
for a given valve size is enhanced in the operating room or
in vitro where the proper balloon size can be determined
by direct visual inspection of the aortic valve. This ability
is more limited in the cardiac catheterization laboratory.
Therefore, we advise the use of smaller balloons initially
with incremental increases in balloon diameter to be deter-
mined by serial measurements of transaortic valve gradient
as well as the response of the patient's blood pressure and
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heart rate to inflations with progressively larger balloons.
It is possible that oversized balloons inflated in small valves
would result in significant disruption of the valve ring with
abrupt aortic regurgitation or death. This is supported by
our finding of leaflet avulsion in one specimen after dilation
with an oversized 25 mm balloon preceded by successful
dilation with a 20 mm balloon.
Limitations of study. Several limitations of our study
deserve mention. First, whereas the cause of most cases of
aortic stenosis can be determined accurately by gross in-
spection of the valve, extremely severe distortions in the
valve by calcium and fibrosis occasionallyprecludeetiologic
assessment (12). However,all valves described in this report
could be accuratelyassessed, and the cause of aortic stenosis
was established in each patient.
Second, valve microfractures presumably were present
in successfully dilated valves that did not show gross changes
in leaflet morphology. This implies that microscopic sec-
tions of valve tissue might have been useful in establishing
the presence of such microfractures. However, we believed
that it would be impossible to distinguish artifacts of fi xation
and cutting from true microfractures associated with balloon
inflations.
Third, 27 of 39 valves were dilated after variable periods
of tixation in formalin. The effect of formalin fixation on
balloon dilation is largely unknown. However, the fact that
there was no apparent difference in results between the
formalin-fi xed specimens and the fresh tissue either at post-
mortem examination or in the operating room, suggests that
formalin fixat ion may not affect balloon dilation.
Finally, while the potential complications of liberation
of calcifi c debris and abrupt valvular regurgitation havebeen
addressed by this study, the likelihood of other complica-
tions cannot be estimated by a postmortem or intraoperative
study. For instance, balloon dilation in vivo could have a
variety of effects on cardiac conduction as well as the in-
duction of serious ventricular arrhythmias. all of which are
clinically relevant. Furthermore, the issues surrounding the
time course of restenosis can only be addressed by clinical
trial.
Conclusion. This postmortem and intraoperative study
supports the application of balloon valvuloplasty in selected
patients withcalcificaortic stenosis. Balloon dilation results
in an increase in leaflet mobility and orifice dimension by
virtue of fractures of nodular calcifications, separation of
fused commissures or presumed microfractures within the
valve leaflets, alone or in combination. Liberation of valve
debris that could serve as a potential source of emboli was
not observed in this study. Midleaflet tears and valve ring
disruption did not occur with balloons of appropriate size,
suggesting that serious acute aortic regurgitation should not
be a major problem. Potential adverse effects of. balloon
inflation include the development of angina, sustained hy-
potension, serious arrhythmias and leaflet avulsions during
the procedure , many of which can be anticipated by careful
attention to the response of the patient to serial inflations
with progressively larger balloons.
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